Stem cells are undifferentiated cells that have the ability to develop into more specialised cell types. They are found in various tissues throughout the body and play a key role in growth, repair, and renewal of tissues throughout life.
In cardiac medicine, stem cell research has explored whether stem cells could be used to regenerate damaged heart muscle after heart attack or in heart failure, replacing muscle cells (cardiomyocytes) destroyed by ischaemia or disease. Laboratory and early clinical studies generated significant interest, with the hope that injecting stem cells into the heart could restore function in areas of scar tissue.
However, after more than two decades of research and multiple clinical trials, the evidence for clinically meaningful regeneration of the human heart using current stem cell approaches has been limited. Large, rigorous trials (including the BAMI and CONCERT-HF trials) have not demonstrated significant improvements in ejection fraction or clinical outcomes compared to standard care. This does not mean the research has been without value: it has deepened understanding of cardiac repair mechanisms and identified potential future directions, including induced pluripotent stem cells (iPSCs) and engineered heart tissue.
Cardiac regenerative medicine remains an active area of scientific investigation. Patients should be cautious about unregulated commercial offerings of stem cell therapy, which are not evidence-based and may be harmful. Advances in this field are likely to emerge from rigorous clinical trials conducted in regulated research settings rather than from private clinics.
« Back to Glossary Index